Advanced search
Publication Cover
Journal of Multidisciplinary Healthcare Volume 15, 2022 - Issue
Submit an article Journal homepage
202
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care

Michael K Porayko1 Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, TN, USAORCID Iconhttps://orcid.org/0000-0003-2862-9217View further author information
ORCID Icon,
Amy Articolo2 Novo Nordisk, Inc, Plainsboro, NJ, USAView further author information
,
Wendy Cerenzia3 CE Outcomes, LLC, Birmingham, AL, USACorrespondence[email protected]
View further author information
,
Brandon Coleman3 CE Outcomes, LLC, Birmingham, AL, USAView further author information
,
Daxa Patel2 Novo Nordisk, Inc, Plainsboro, NJ, USAView further author information
&
Sylvie Stacy3 CE Outcomes, LLC, Birmingham, AL, USAView further author information
Pages 1533-1545 | Published online: 19 Jul 2022

References

  • Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–1864. doi:10.1053/j.gastro.2020.01.052
  • Kanwal F, Shubrook JH, Adams LA, et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161(5):1657–1669. doi:10.1053/j.gastro.2021.07.049
  • Wieland AC, Quallick M, Truesdale A, Mettler P, Bambha KM. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2013;58(10):2809–2816. doi:10.1007/s10620-013-2740-8
  • Cook N, Geier A, Schmid A, et al. Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis. JHEP Rep. 2020;2(2):100081. doi:10.1016/j.jhepr.2020.100081
  • Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology. 2003;37(5):1202–1219. doi:10.1053/jhep.2003.50193
  • Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54(3):603–608. doi:10.2337/diabetes.54.3.603
  • Promrat K, Kleiner DE, Niemeier HM, et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010;51(1):121–129. doi:10.1002/hep.23276
  • Negi CK, Babica P, Bajard L, Bienertova-Vasku J, Tarantino G. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. Metabolism. 2022;126:154925. doi:10.1016/j.metabol.2021.154925 PMID: 34740573.
  • Balakrishnan M, Loomba R. The role of noninvasive tests for differentiating NASH from NAFL and diagnosing advanced fibrosis among patients with NAFLD. J Clin Gastroenterol. 2020;54(2):107–113. doi:10.1097/MCG.0000000000001284
  • Blais P, Husain N, Kramer JR, Kowalkowski M, El-Serag H, Kanwal F. Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015;110(1):10–14. doi:10.1038/ajg.2014.134
  • Polanco-Briceno S, Glass D, Stuntz M, Caze A. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists. BMC Res Notes. 2016;9:157. doi:10.1186/s13104-016-1946-1
  • Saeed N, Glass LM, Habbal H, et al. Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey. Therap Adv Gastroenterol. 2021;14:17562848211042200. doi:10.1177/17562848211042200
  • Younossi ZM, Ong JP, Takahashi H, et al. A global survey of physicians knowledge about nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2021;20:e1456–e1468.
  • Kanwal F, Shubrook JH, Younossi Z, et al. Preparing for the NASH epidemic: a call to action. Metabolism. 2021;122:154822. doi:10.1016/j.metabol.2021.154822
  • Casler K, Trees K, Bosak K. Providing care for fatty liver disease patients: primary care nurse practitioners’ knowledge, actions, and preparedness. Gastroenterol Nurs. 2020;43(5):E184–E189. doi:10.1097/SGA.0000000000000487
  • Cobbold JFL, Raveendran S, Peake CM, Anstee QM, Yee MS, Thursz MR. Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience. Frontline Gastroenterol. 2013;4(4):263–269. doi:10.1136/flgastro-2013-100319
  • Moolla A, Motohashi K, Marjot T, et al. A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health. Frontline Gastroenterol. 2019;10(4):337–346. doi:10.1136/flgastro-2018-101155
  • Peabody JW, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141(10):771–780. doi:10.7326/0003-4819-141-10-200411160-00008
  • Luck J, Peabody JW, Lewis BL. An automated scoring algorithm for computerized clinical vignettes: evaluating physician performance against explicit quality criteria. Int J Med Inform. 2006;75(10–11):701–707. doi:10.1016/j.ijmedinf.2005.10.005
  • Patel P, Muller C, Paul S. Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: a systematic review and meta-analysis. World J Hepatol. 2020;12(8):506–518. doi:10.4254/wjh.v12.i8.506
  • Rich NE, Oji S, Mufti AR, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(2):198–210.e2. doi:10.1016/j.cgh.2017.09.041

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.